Stocks · Health care · Hospital & Medical Service Plans

CLOVER HEALTH INVESTMENTS, CORP.

CLOV Clue Score51
United States Fiscal year ends December CIK 0001801170 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Anna U Loengard
13 Aug 2025
Director
Buy indirect
14,500
$2.59
$37.56K
Anna U Loengard
13 Aug 2025
Director
Buy indirect
12,000
$2.60
$31.20K
Vivek Garipalli
8 Aug 2025
Director
Buy
31,980
$2.17
$69.40K
Vivek Garipalli
7 Aug 2025
Director
Buy
415,000
$2.24
$929.60K
Vivek Garipalli
9 Aug 2024
Director
Buy
531,700
$1.88
$999.60K
Vivek Garipalli
17 Jun 2024
Director
Buy
877,567
$1.14
$1.00M
Anna U Loengard
17 May 2024
Director
Buy indirect
10,000
$0.93
$9.30K
Anna U Loengard
16 May 2024
Director
Buy indirect
1,485
$0.94
$1.40K
Anna U Loengard
16 May 2024
Director
Buy indirect
15,600
$0.96
$14.98K
Anna U Loengard
14 Mar 2024
Director
Buy indirect
13,625
$0.73
$9.95K
Anna U Loengard
14 Mar 2024
Director
Buy
137,000
$0.73
$100.01K
Anna U Loengard
6 Sep 2023
Director
Buy indirect
500
$1.30
$650.00
Anna U Loengard
6 Sep 2023
Director
Buy indirect
500
$1.30
$650.00
Anna U Loengard
6 Sep 2023
Director
Buy indirect
10,000
$1.30
$13.00K
Lee Shapiro
11 Mar 2022
Director
Buy
80,000
$3.10
$248.07K
Chelsea Clinton
3 Mar 2022
Director
Buy
100,000
$2.53
$252.53K
Chamath Palihapitiya
22 Nov 2021
10% owner
Buy indirect
1,739,130
$5.75
$10.00M

What was left out

Form 4 filings counted 305
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 47
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 152,934,025
History held since 11 Jan 2021